New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions Book

1	Introduction and background	7
2	Clinical trials	16
3	Treatment, financing, and costs	23
4	Behavioral responses and consent	37
App. A	Vaccines and depot medications for drug addiction : rationale, mechanisms of action, and treatment implications	63
App. B	What will we learn from the FDA clinical trials process and what will we still want to know about immunotherapies and depot medications to treat drug dependence?	98
App. C	Putting addiction treatment medications to use : lessons learned	125
App. D	Adoption of drug abuse treatment technology in specialty and primary care settings	140
App. E	The use of immunotherapies and sustained-release formulations in the treatment of drug addiction : will current law support coercion?	173
App. F	Ethical issues in immunotherapies and depot medications for the substance abuse	188
App. G	Costs and benefits of immunotherapies or depot medications for the treatment of drug abuse	213
App. H	Anticipating unintended consequences of vaccine-like immunotherapies and depot medications for addictive drug use	241
App. I	Vaccines and immunotherapies to control addiction in minors : the legal framework	276